Boston Scientific will build a $138 million, 500,000 sq ft facility in Plainfield, Indiana that combines distribution, light manufacturing, and regulatory compliance under one roof. For an operator handling regulated products, the DC doubles as a compliance node.
How it’s built: The facility combines three functions that often operate in separate buildings. These are fulfillment, light manufacturing, and regulatory compliance. They are connected through automation and AI systems. For sterile, FDA-governed medical devices, placing compliance and assembly in the same location as distribution shortens the quality and recall feedback loop and removes a chain-of-custody break between sites. The project is expected to create up to 300 jobs.
The network logic: The site is about 40 miles from Boston Scientific’s Spencer, Indiana plant, which produces endoscopy and urology scopes. That gives the company a short inbound lane from manufacturing to DC.
It joins existing US distribution in Quincy, Massachusetts, the company’s roughly 630,000 sq ft main US hub, along with facilities in Brooklyn Park, Minnesota and Johns Creek, Georgia. Combined, the network is designed to support distribution to 48 million patients a year.
According to the company’s annual report, the strategy is to “bring distribution closer to the customer” while “infusing AI and automation” across the supply chain.
A bigger pattern: Indiana is becoming a hub for regulated-product distribution. Cardinal Health announced a 230,000 sq ft automated pharmaceutical DC in Indianapolis, built on Swisslog robotics.
Medical device and pharmaceutical supply chains are regionalizing and integrating compliance and automation into DC operations. The shift is being driven by near-shoring, business continuity risk, and tighter lead-time requirements for regulated goods.
The compliance logic: In regulated supply chains such as medical devices, pharmaceuticals, specialty food and hazardous materials, the DC is taking on compliance work it once handed off to separate sites. Bringing light manufacturing, regulatory review, and distribution into one building shortens lead times, reduces recall risk, and keeps chain of custody intact. The tradeoff is operating fewer but more capable sites at a higher cost per location.
